0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Wearable Patch Market by Product (Temperature Patch, Blood Glucose Patch, Blood Pressure Patch, Heart Rate Patch & ECG Patch, Skin Care Patch, and Others) and End Use (Healthcare and Fitness and Sports): Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: March 2021
|
Report Code: ALLI-Manu-3J46
Home | Category |Health |Medical Devices & Equipment
Wearable Patch Market

Wearable Patch Market by Product (Temperature Patch, Blood Glucose Patch, Blood Pressure Patch, Heart Rate Patch & ECG Patch, Skin Care Patch, and Others) and End Use (Healthcare and Fitness and Sports): Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Manu-3J46
Report
March 2021
206 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

WEARABLE PATCH MARKET OVERVIEW

The global wearable patch market size was valued at $12,239.7 million in 2019, and is projected to reach $27,820.5 million by 2027, registering a CAGR of 9.6% from 2020 to 2027.

 

Wearable patch, also known as smart patch or electronic skin, is used for disease monitoring, drug delivery, and diagnosis. Wearable patches help to maintain health and wellbeing in elderly patients suffering from chronic conditions such as diabetes and cardiovascular diseases.

Wearable Patch Market

 

Rise in technological advancements in wearable patches, increase in prevalence of chronic diseases, and growth in awareness among consumers regarding wearable patches are the major factors that propel the market growth. In addition, rise in technological advancements in wearable patches also drive the market growth. Features such as continuous monitoring of patients, coupled with precise data, minimal interference with body movements, and easier connectivity with smartphones assist the wearable patch market growth. For instance, Koninklijke Philips N.V. received the United States Food and Drug Administration (USFDA) approval for Philips Biosensor BX100, a disposable wearable sensor patch in May 2020, which can track heart rate and respiratory rate, once a patient is discharged from intensive care unit.

Connected wearables are portable in nature, feature wireless connectivity, and are mostly used to monitor heart rate via Bluetooth. It also uses microprocessor controller and myoelectric technology. Moreover, these patches are compatible with most mobile operating systems and can be connected easily through Bluetooth. Connected wearable patches collect data at regular intervals and transmit it to connected devices such as smartphones and laptops. They eliminate the need for physical consultation with doctors by remotely monitoring health of patients.

However, high cost of sensor patches and concerns regarding data privacy and security hamper the wearable patch market growth. For instance, average price of electrocardiogram sensor patch is between $ 300 and $ 4,500.

 

Global Wearable Patch Market Segmentation

The wearable patch market is categorized into product, end use, and region. On the basis of product, the market is segmented into temperature patch, blood glucose patch, blood pressure patch, heart rate patch & ECG patch, skin care patch, and others. The blood glucose patch measures glucose levels in the interstitial fluid between the cells under the skin. The blood glucose patch segment led the market in 2019, and is expected to continue this trend throughout the forecast period, as several patients with diabetes are advised to monitor blood glucose on a regular basis to prevent development of hyperglycemia or hypoglycemia and to facilitate control over diabetes. 

By end use, the global wearable patch medical market is segregated into healthcare and fitness and sports. The fitness and sports segment is expected to witness considerable market growth during the forecast period, owing to gradual increase in use of wearable patches by athletes to gain health data insights to support their performance. For instance, Abbott Laboratories’ Libre Sense Glucose Sport Biosensor is designed for sports use and provides streaming glucose data with a dynamic range of 55-200 mg/dL for performance athletes to monitor their glucose levels. Biosensors are designed to provide glucose monitoring experience that enable athletes understand efficacy of their nutrition choices during training and competition. It informs athletes to take nutrition appropriately, to fill their glycogen stores prior to a race and to know when to replenish during a race in order to maintain athletic performance.

Region wise, the wearable patch market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The market in Asia-Pacific is expected to register the fastest CAGR during the forecast period pertaining to presence of large population base, increase in awareness regarding wearable patches, and rise in disposable income. Increase in need to provide cost-effective and quality clinical care to patients propels implementation and integration of medical devices and healthcare IT solutions in this region, which creates opportunities for existing companies and new market entrants.

The wearable patch market is highly competitive in nature, as major players in this vertical are concentrating on growth strategies such as product launches, mergers and acquisitions (M&As), partnerships and collaborations to gain competitive advantage. For instance, in June 2020, in the U.S., Abbott laboratories received an approval from the USFDA for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children aged above 4 suffering from diabetes.

The key players operating in the global wearable patch market include Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., L’Oreal Group, LifeSignals, Inc., Medtronic Plc (Zephyr Technology Corporation), Qualcomm Technologies, Inc., VitalConnect, Inc., and VivaLNK. 

 

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global wearable patch market size along with the current trends and future estimations to elucidate the imminent investment pockets
  • It offers wearable patch market analysis from 2020 to 2027, which is expected to enable stakeholders to capitalize on the prevailing opportunities in the market
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global wearable patch market growth

 

Key Market Segments

By Product

  • Temperature Patch
  • Blood Glucose Patch
  • Blood Pressure Patch
  • Heart Rate Patch & ECG Patch
  • Skin Care Patch
  • Others

By End Use

  • Healthcare
  • Fitness & Sports

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

List Of Key Players Profiled In The Report

  • Abbott Laboratories
  • iRhythm Technologies, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • L’Oreal Group
  • LifeSignals, Inc.
  • Medtronic Plc (Zephyr Technology Corporation)
  • Qualcomm Technologies, Inc.
  • VitalConnect, Inc.
  • VivaLNK

 

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

 

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

 

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s five forces analysis

3.4.Top player positioning, 2019

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increasing technological advancements in wearable patch

3.5.1.2.Growing awareness among consumers regarding wearable patch

3.5.1.3.Rising prevalence of chronic diseases

3.5.1.4.Increased demand for the connected wearable patches

3.5.2.Restraints

3.5.2.1.High cost of sensor patch

3.5.2.2.Concerns regarding data privacy and security

3.5.3.Opportunity

3.5.3.1.Increase in adoption of telehealth

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on wearable patch market

 

CHAPTER 4:WEARABLE PATCH MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Temperature patch

4.2.1.Market size and forecast, by region

4.2.2.Market analysis, by country

4.3.Blood glucose patch

4.3.1.Market size and forecast, by region

4.3.2.Market analysis, by country

4.4.Blood pressure patch

4.4.1.Market size and forecast, by region

4.4.2.Market analysis, by country

4.5.Heart rate patch & ECG patch

4.5.1.Market size and forecast, by region

4.5.2.Market analysis, by country

4.6.Skin care patch

4.6.1.Market size and forecast, by region

4.6.2.Market analysis, by country

4.7.Others

4.7.1.Market size and forecast, by region

4.7.2.Market analysis, by country

 

CHAPTER 5:WEARABLE PATCH MARKET, BY END USE

5.1.Overview

5.1.1.Market size and forecast

5.2.Healthcare

5.2.1.Market size and forecast, by region

5.2.2.Market analysis, by country

5.3.Fitness and sports

5.3.1.Market size and forecast, by region

5.3.2.Market analysis, by country

 

CHAPTER 6:WEARABLE PATCH MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.North America market size and forecast, by product

6.2.2.North America market size and forecast, by end use

6.2.3.North America market size and forecast, by country

6.2.4.U.S.

6.2.4.1.U.S. market size and forecast, by product

6.2.4.2.U.S. market size and forecast, by end use

6.2.5.Canada

6.2.5.1.Canada market size and forecast, by product

6.2.5.2.Canada market size and forecast, by end use

6.2.6.Mexico

6.2.6.1.Mexico market size and forecast, by product

6.2.6.2.Mexico market size and forecast, by end use

6.3.Europe

6.3.1.Europe market size and forecast, by product

6.3.2.Europe market size and forecast, by end use

6.3.3.Europe market size and forecast, by country

6.3.4.Germany

6.3.4.1.Germany market size and forecast, by product

6.3.4.2.Germany market size and forecast, by end use

6.3.5.France

6.3.5.1.France market size and forecast, by product

6.3.5.2.France market size and forecast, by end use

6.3.6.UK

6.3.6.1.UK market size and forecast, by product

6.3.6.2.UK market size and forecast, by end use

6.3.7.Italy

6.3.7.1.Italy market size and forecast, by product

6.3.7.2.Italy market size and forecast, by end use

6.3.8.Spain

6.3.8.1.Spain market size and forecast, by product

6.3.8.2.Spain market size and forecast, by end use

6.3.9.Rest of Europe

6.3.9.1.Rest of Europe market size and forecast, by product

6.3.9.2.Rest of Europe market size and forecast, by end use

6.4.Asia-Pacific

6.4.1.Asia-Pacific market size and forecast, by product

6.4.2.Asia-Pacific market size and forecast, by end use

6.4.3.Asia-Pacific market size and forecast, by country

6.4.4.Japan

6.4.4.1.Japan market size and forecast, by product

6.4.4.2.Japan market size and forecast, by end use

6.4.5.China

6.4.5.1.China market size and forecast, by product

6.4.5.2.China market size and forecast, by end use

6.4.6.Australia

6.4.6.1.Australia market size and forecast, by product

6.4.6.2.Australia market size and forecast, by end use

6.4.7.India

6.4.7.1.India market size and forecast, by product

6.4.7.2.India market size and forecast, by end use

6.4.8.South Korea

6.4.8.1.South Korea market size and forecast, by product

6.4.8.2.South Korea market size and forecast, by end use

6.4.9.Rest of Asia-Pacific

6.4.9.1.Rest of Asia-Pacific market size and forecast, by product

6.4.9.2.Rest of Asia-Pacific market size and forecast, by end use

6.5.LAMEA

6.5.1.LAMEA market size and forecast, by product

6.5.2.LAMEA market size and forecast, by end use

6.5.3.LAMEA market size and forecast, by country

6.5.4.Brazil

6.5.4.1.Brazil market size and forecast, by product

6.5.4.2.Brazil market size and forecast, by end use

6.5.5.Saudi Arabia

6.5.5.1.Saudi Arabia market size and forecast, by product

6.5.5.2.Saudi Arabia market size and forecast, by end use

6.5.6.South Africa

6.5.6.1.South Africa market size and forecast, by product

6.5.6.2.South Africa market size and forecast, by end use

6.5.7.Rest of LAMEA

6.5.7.1.Rest of LAMEA market size and forecast, by product

6.5.7.2.Rest of LAMEA market size and forecast, by end use

 

CHAPTER 7:COMPANY PROFILES

7.1.Abbott Laboratories

7.1.1.Company overview

7.1.2.Company snapshot

7.1.3.Operating business segments

7.1.4.Product portfolio

7.1.5.Business performance

7.1.6.Key strategic moves and developments

7.2.iRhythm Technologies, Inc.

7.2.1.Company overview

7.2.2.Company snapshot

7.2.3.Operating business segments

7.2.4.Product portfolio

7.2.5.Business performance

7.2.6.Key strategic moves and developments

7.3.Johnson & Johnson Services, Inc.

7.3.1.Company overview

7.3.2.Company snapshot

7.3.3.Operating business segments

7.3.4.Product portfolio

7.3.5.Business performance

7.3.6.Key strategic moves and developments

7.4.Koninklijke Philips N.V.

7.4.1.Company overview

7.4.2.Company snapshot

7.4.3.Operating business segments

7.4.4.Product portfolio

7.4.5.Business performance

7.4.6.Key strategic moves and developments

7.5.L’Oreal Group

7.5.1.Company overview

7.5.2.Company snapshot

7.5.3.Operating business segments

7.5.4.Product portfolio

7.5.5.Business performance

7.5.6.Key strategic moves and developments

7.6.LifeSignals, Inc.

7.6.1.Company overview

7.6.2.Company snapshot

7.6.3.Operating business segments

7.6.4.Product portfolio

7.6.5.Key strategic moves and developments

7.7.Medtronic plc (Zephyr Technology Corporation)

7.7.1.Company overview

7.7.2.Company snapshot

7.7.3.Operating business segments

7.7.4.Product portfolio

7.7.5.Business performance

7.8.Qualcomm Technologies, Inc.

7.8.1.Company overview

7.8.2.Company snapshot

7.8.3.Operating business segments

7.8.4.Product portfolio

7.8.5.Business performance

7.9.VitalConnect , Inc.

7.9.1.Company overview

7.9.2.Company snapshot

7.9.3.Operating business segments

7.9.4.Product portfolio

7.9.5.Key strategic moves and developments

7.10.VivaLNK

7.10.1.Company overview

7.10.2.Company snapshot

7.10.3.Operating business segments

7.10.4.Product portfolio

7.10.5.Key strategic moves and developments



LIST OF TABLES

 

TABLE 01.GLOBAL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 02.GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 03.GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 04.GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 05.GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 06.GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 07.GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)

TABLE 08.GLOBAL WEARABLE PATCH MARKET, BY END USE, 2019–2027 ($MILLION)

TABLE 09.GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY REGION, 2019–2027 ($MILLION)

TABLE 10.GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY REGION, 2019–2027 ($MILLION)

TABLE 11.WEARABLE PATCH MARKET, BY REGION, 2019–2027, ($MILLION)85

TABLE 12.NORTH AMERICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 13.NORTH AMERICA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 14.NORTH AMERICA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 15.U.S. WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 16.U.S. WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 17.CANADA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 18.CANADA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 19.MEXICO WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 20.MEXICO WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 21.EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 22.EUROPE WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 23.EUROPE WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 24.GERMANY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 25.GERMANY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 26.FRANCE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 27.FRANCE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 28.UK WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 29.UK WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 30.ITALY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 31.ITALY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 32.SPAIN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 33.SPAIN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 34.REST OF EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 35.REST OF EUROPE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 36.ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 37.ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 38.ASIA-PACIFIC WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 39.JAPAN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 40.JAPAN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 41.CHINA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 42.CHINA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 43.AUSTRALIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 44.AUSTRALIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 45.INDIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 46.INDIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 47.SOUTH KOREA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 48.SOUTH KOREA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 49.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 50.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 51.LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 52.LAMEA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 53.LAMEA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 54.BRAZIL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 55.BRAZIL WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 56.SAUDI ARABIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 57.SAUDI ARABIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 58.SOUTH AFRICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 59.SOUTH AFRICA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 60.REST OF LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 61.REST OF LAMEA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 62.ABBOTT: COMPANY SNAPSHOT

TABLE 63.ABBOTT: OPERATING BUSINESS SEGMENTS

TABLE 64.ABBOTT: PRODUCT PORTFOLIO

TABLE 65.IRHYTHM: COMPANY SNAPSHOT

TABLE 66.IRHYTHM: OERATING SEGMENT

TABLE 67.IRHYTHM: PRODUCT PORTFOLIO

TABLE 68.J&J: COMPANY SNAPSHOT

TABLE 69.J&J: OPERATING BUSINESS SEGMENTS

TABLE 70.J&J: PRODUCT PORTFOLIO

TABLE 71.PHILIPS: COMPANY SNAPSHOT

TABLE 72.PHILIPS: OPERATING SEGMENTS

TABLE 73.PHILIPS: PRODUCT PORTFOLIO

TABLE 74.L’OREAL: COMPANY SNAPSHOT

TABLE 75.L’OREAL: OPERATING SEGMENTS

TABLE 76.L’OREAL: PRODUCT PORTFOLIO

TABLE 77.LIFESIGNALS: COMPANY SNAPSHOT

TABLE 78.LIFESIGNALS: OERATING SEGMENT

TABLE 79.LIFESIGNALS: PRODUCT PORTFOLIO

TABLE 80.MEDTRONIC: COMPANY SNAPSHOT

TABLE 81.MEDTRONIC: OPERATING SEGMENTS

TABLE 82.MEDTRONIC: PRODUCT PORTFOLIO

TABLE 83.QUALCOMM: COMPANY SNAPSHOT

TABLE 84.: OERATING SEGMENT

TABLE 85.QUALCOMM: PRODUCT PORTFOLIO

TABLE 86.VITALCONNECT: COMPANY SNAPSHOT

TABLE 87.VITALCONNECT: OERATING SEGMENT

TABLE 88.VITALCONNECT: PRODUCT PORTFOLIO

TABLE 89.VIVALNK: COMPANY SNAPSHOT

TABLE 90.VIVALNK: OERATING SEGMENT

TABLE 91.VIVALNK: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL WEARABLE PATCH MARKET SEGMENTATION

FIGURE 02.TOP INVESTMENT POCKETS

FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020

FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020

FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020

FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS

FIGURE 07.HIGH BARGAINING POWER OF BUYERS

FIGURE 08.HIGH THREAT OF SUBSTITUTES

FIGURE 09.MODERATE THREAT OF NEW ENTRANTS

FIGURE 10.MODERATE INTENSITY OF RIVALRY

FIGURE 11.TOP PLAYER POSITIONING, 2019

FIGURE 12.IMPACT ANALYSIS

FIGURE 13.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 14.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 15.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 16.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 17.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 18.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 19.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY COUNTRY, 2019 & 2027 (%)

FIGURE 20.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 21.ABBOTT: NET SALES, 2017–2019 ($MILLION)

FIGURE 22.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 23.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 24.IRHYTHM: NET SALES, 2017–2019 ($MILLION)

FIGURE 25.J&J: NET SALES, 2017–2019 ($MILLION)

FIGURE 26.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 27.J&J: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 28.PHILIPS: NET SALES, 2017–2019 ($MILLION)

FIGURE 29.PHILIPS: REVENUE SHARE BY SEGMENT, 2019 (%)

FIGURE 30.PHILIPS: REVENUE SHARE BY REGION, 2019(%)

FIGURE 31.L’OREAL: NET SALES, 2017–2019 ($MILLION)

FIGURE 32.L’OREAL: REVENUE SHARE BY SEGMENT, 2019 (%)

FIGURE 33.L’OREAL: REVENUE SHARE BY REGION, 2019 (%)

FIGURE 34.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)

FIGURE 35.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)

FIGURE 36.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)

FIGURE 37.QUALCOMM: NET SALES, 2018–2020 ($MILLION)

FIGURE 38.QUALCOMM: REVENUE SHARE, BY SEGMENT, 2020 (%)

FIGURE 39.QUALCOMM: REVENUE SHARE, BY REGION, 2020 (%)

 

WEARABLE PATCH MARKET OVERVIEW

The global wearable patch market size was valued at $12,239.7 million in 2019, and is projected to reach $27,820.5 million by 2027, registering a CAGR of 9.6% from 2020 to 2027.

 

Wearable patch, also known as smart patch or electronic skin, is used for disease monitoring, drug delivery, and diagnosis. Wearable patches help to maintain health and wellbeing in elderly patients suffering from chronic conditions such as diabetes and cardiovascular diseases.

Wearable Patch Market

 

Rise in technological advancements in wearable patches, increase in prevalence of chronic diseases, and growth in awareness among consumers regarding wearable patches are the major factors that propel the market growth. In addition, rise in technological advancements in wearable patches also drive the market growth. Features such as continuous monitoring of patients, coupled with precise data, minimal interference with body movements, and easier connectivity with smartphones assist the wearable patch market growth. For instance, Koninklijke Philips N.V. received the United States Food and Drug Administration (USFDA) approval for Philips Biosensor BX100, a disposable wearable sensor patch in May 2020, which can track heart rate and respiratory rate, once a patient is discharged from intensive care unit.

Connected wearables are portable in nature, feature wireless connectivity, and are mostly used to monitor heart rate via Bluetooth. It also uses microprocessor controller and myoelectric technology. Moreover, these patches are compatible with most mobile operating systems and can be connected easily through Bluetooth. Connected wearable patches collect data at regular intervals and transmit it to connected devices such as smartphones and laptops. They eliminate the need for physical consultation with doctors by remotely monitoring health of patients.

However, high cost of sensor patches and concerns regarding data privacy and security hamper the wearable patch market growth. For instance, average price of electrocardiogram sensor patch is between $ 300 and $ 4,500.

 

Global Wearable Patch Market Segmentation

The wearable patch market is categorized into product, end use, and region. On the basis of product, the market is segmented into temperature patch, blood glucose patch, blood pressure patch, heart rate patch & ECG patch, skin care patch, and others. The blood glucose patch measures glucose levels in the interstitial fluid between the cells under the skin. The blood glucose patch segment led the market in 2019, and is expected to continue this trend throughout the forecast period, as several patients with diabetes are advised to monitor blood glucose on a regular basis to prevent development of hyperglycemia or hypoglycemia and to facilitate control over diabetes. 

By end use, the global wearable patch medical market is segregated into healthcare and fitness and sports. The fitness and sports segment is expected to witness considerable market growth during the forecast period, owing to gradual increase in use of wearable patches by athletes to gain health data insights to support their performance. For instance, Abbott Laboratories’ Libre Sense Glucose Sport Biosensor is designed for sports use and provides streaming glucose data with a dynamic range of 55-200 mg/dL for performance athletes to monitor their glucose levels. Biosensors are designed to provide glucose monitoring experience that enable athletes understand efficacy of their nutrition choices during training and competition. It informs athletes to take nutrition appropriately, to fill their glycogen stores prior to a race and to know when to replenish during a race in order to maintain athletic performance.

Region wise, the wearable patch market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The market in Asia-Pacific is expected to register the fastest CAGR during the forecast period pertaining to presence of large population base, increase in awareness regarding wearable patches, and rise in disposable income. Increase in need to provide cost-effective and quality clinical care to patients propels implementation and integration of medical devices and healthcare IT solutions in this region, which creates opportunities for existing companies and new market entrants.

The wearable patch market is highly competitive in nature, as major players in this vertical are concentrating on growth strategies such as product launches, mergers and acquisitions (M&As), partnerships and collaborations to gain competitive advantage. For instance, in June 2020, in the U.S., Abbott laboratories received an approval from the USFDA for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children aged above 4 suffering from diabetes.

The key players operating in the global wearable patch market include Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., L’Oreal Group, LifeSignals, Inc., Medtronic Plc (Zephyr Technology Corporation), Qualcomm Technologies, Inc., VitalConnect, Inc., and VivaLNK. 

 

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global wearable patch market size along with the current trends and future estimations to elucidate the imminent investment pockets
  • It offers wearable patch market analysis from 2020 to 2027, which is expected to enable stakeholders to capitalize on the prevailing opportunities in the market
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global wearable patch market growth

 

Key Market Segments

By Product

  • Temperature Patch
  • Blood Glucose Patch
  • Blood Pressure Patch
  • Heart Rate Patch & ECG Patch
  • Skin Care Patch
  • Others

By End Use

  • Healthcare
  • Fitness & Sports

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

List Of Key Players Profiled In The Report

  • Abbott Laboratories
  • iRhythm Technologies, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • L’Oreal Group
  • LifeSignals, Inc.
  • Medtronic Plc (Zephyr Technology Corporation)
  • Qualcomm Technologies, Inc.
  • VitalConnect, Inc.
  • VivaLNK

 

Read More

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

 

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

 

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s five forces analysis

3.4.Top player positioning, 2019

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increasing technological advancements in wearable patch

3.5.1.2.Growing awareness among consumers regarding wearable patch

3.5.1.3.Rising prevalence of chronic diseases

3.5.1.4.Increased demand for the connected wearable patches

3.5.2.Restraints

3.5.2.1.High cost of sensor patch

3.5.2.2.Concerns regarding data privacy and security

3.5.3.Opportunity

3.5.3.1.Increase in adoption of telehealth

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on wearable patch market

 

CHAPTER 4:WEARABLE PATCH MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Temperature patch

4.2.1.Market size and forecast, by region

4.2.2.Market analysis, by country

4.3.Blood glucose patch

4.3.1.Market size and forecast, by region

4.3.2.Market analysis, by country

4.4.Blood pressure patch

4.4.1.Market size and forecast, by region

4.4.2.Market analysis, by country

4.5.Heart rate patch & ECG patch

4.5.1.Market size and forecast, by region

4.5.2.Market analysis, by country

4.6.Skin care patch

4.6.1.Market size and forecast, by region

4.6.2.Market analysis, by country

4.7.Others

4.7.1.Market size and forecast, by region

4.7.2.Market analysis, by country

 

CHAPTER 5:WEARABLE PATCH MARKET, BY END USE

5.1.Overview

5.1.1.Market size and forecast

5.2.Healthcare

5.2.1.Market size and forecast, by region

5.2.2.Market analysis, by country

5.3.Fitness and sports

5.3.1.Market size and forecast, by region

5.3.2.Market analysis, by country

 

CHAPTER 6:WEARABLE PATCH MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.North America market size and forecast, by product

6.2.2.North America market size and forecast, by end use

6.2.3.North America market size and forecast, by country

6.2.4.U.S.

6.2.4.1.U.S. market size and forecast, by product

6.2.4.2.U.S. market size and forecast, by end use

6.2.5.Canada

6.2.5.1.Canada market size and forecast, by product

6.2.5.2.Canada market size and forecast, by end use

6.2.6.Mexico

6.2.6.1.Mexico market size and forecast, by product

6.2.6.2.Mexico market size and forecast, by end use

6.3.Europe

6.3.1.Europe market size and forecast, by product

6.3.2.Europe market size and forecast, by end use

6.3.3.Europe market size and forecast, by country

6.3.4.Germany

6.3.4.1.Germany market size and forecast, by product

6.3.4.2.Germany market size and forecast, by end use

6.3.5.France

6.3.5.1.France market size and forecast, by product

6.3.5.2.France market size and forecast, by end use

6.3.6.UK

6.3.6.1.UK market size and forecast, by product

6.3.6.2.UK market size and forecast, by end use

6.3.7.Italy

6.3.7.1.Italy market size and forecast, by product

6.3.7.2.Italy market size and forecast, by end use

6.3.8.Spain

6.3.8.1.Spain market size and forecast, by product

6.3.8.2.Spain market size and forecast, by end use

6.3.9.Rest of Europe

6.3.9.1.Rest of Europe market size and forecast, by product

6.3.9.2.Rest of Europe market size and forecast, by end use

6.4.Asia-Pacific

6.4.1.Asia-Pacific market size and forecast, by product

6.4.2.Asia-Pacific market size and forecast, by end use

6.4.3.Asia-Pacific market size and forecast, by country

6.4.4.Japan

6.4.4.1.Japan market size and forecast, by product

6.4.4.2.Japan market size and forecast, by end use

6.4.5.China

6.4.5.1.China market size and forecast, by product

6.4.5.2.China market size and forecast, by end use

6.4.6.Australia

6.4.6.1.Australia market size and forecast, by product

6.4.6.2.Australia market size and forecast, by end use

6.4.7.India

6.4.7.1.India market size and forecast, by product

6.4.7.2.India market size and forecast, by end use

6.4.8.South Korea

6.4.8.1.South Korea market size and forecast, by product

6.4.8.2.South Korea market size and forecast, by end use

6.4.9.Rest of Asia-Pacific

6.4.9.1.Rest of Asia-Pacific market size and forecast, by product

6.4.9.2.Rest of Asia-Pacific market size and forecast, by end use

6.5.LAMEA

6.5.1.LAMEA market size and forecast, by product

6.5.2.LAMEA market size and forecast, by end use

6.5.3.LAMEA market size and forecast, by country

6.5.4.Brazil

6.5.4.1.Brazil market size and forecast, by product

6.5.4.2.Brazil market size and forecast, by end use

6.5.5.Saudi Arabia

6.5.5.1.Saudi Arabia market size and forecast, by product

6.5.5.2.Saudi Arabia market size and forecast, by end use

6.5.6.South Africa

6.5.6.1.South Africa market size and forecast, by product

6.5.6.2.South Africa market size and forecast, by end use

6.5.7.Rest of LAMEA

6.5.7.1.Rest of LAMEA market size and forecast, by product

6.5.7.2.Rest of LAMEA market size and forecast, by end use

 

CHAPTER 7:COMPANY PROFILES

7.1.Abbott Laboratories

7.1.1.Company overview

7.1.2.Company snapshot

7.1.3.Operating business segments

7.1.4.Product portfolio

7.1.5.Business performance

7.1.6.Key strategic moves and developments

7.2.iRhythm Technologies, Inc.

7.2.1.Company overview

7.2.2.Company snapshot

7.2.3.Operating business segments

7.2.4.Product portfolio

7.2.5.Business performance

7.2.6.Key strategic moves and developments

7.3.Johnson & Johnson Services, Inc.

7.3.1.Company overview

7.3.2.Company snapshot

7.3.3.Operating business segments

7.3.4.Product portfolio

7.3.5.Business performance

7.3.6.Key strategic moves and developments

7.4.Koninklijke Philips N.V.

7.4.1.Company overview

7.4.2.Company snapshot

7.4.3.Operating business segments

7.4.4.Product portfolio

7.4.5.Business performance

7.4.6.Key strategic moves and developments

7.5.L’Oreal Group

7.5.1.Company overview

7.5.2.Company snapshot

7.5.3.Operating business segments

7.5.4.Product portfolio

7.5.5.Business performance

7.5.6.Key strategic moves and developments

7.6.LifeSignals, Inc.

7.6.1.Company overview

7.6.2.Company snapshot

7.6.3.Operating business segments

7.6.4.Product portfolio

7.6.5.Key strategic moves and developments

7.7.Medtronic plc (Zephyr Technology Corporation)

7.7.1.Company overview

7.7.2.Company snapshot

7.7.3.Operating business segments

7.7.4.Product portfolio

7.7.5.Business performance

7.8.Qualcomm Technologies, Inc.

7.8.1.Company overview

7.8.2.Company snapshot

7.8.3.Operating business segments

7.8.4.Product portfolio

7.8.5.Business performance

7.9.VitalConnect , Inc.

7.9.1.Company overview

7.9.2.Company snapshot

7.9.3.Operating business segments

7.9.4.Product portfolio

7.9.5.Key strategic moves and developments

7.10.VivaLNK

7.10.1.Company overview

7.10.2.Company snapshot

7.10.3.Operating business segments

7.10.4.Product portfolio

7.10.5.Key strategic moves and developments



Read More

LIST OF TABLES

 

TABLE 01.GLOBAL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 02.GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 03.GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 04.GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 05.GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 06.GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY REGION, 2019–2027 ($MILLION)

TABLE 07.GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)

TABLE 08.GLOBAL WEARABLE PATCH MARKET, BY END USE, 2019–2027 ($MILLION)

TABLE 09.GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY REGION, 2019–2027 ($MILLION)

TABLE 10.GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY REGION, 2019–2027 ($MILLION)

TABLE 11.WEARABLE PATCH MARKET, BY REGION, 2019–2027, ($MILLION)85

TABLE 12.NORTH AMERICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 13.NORTH AMERICA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 14.NORTH AMERICA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 15.U.S. WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 16.U.S. WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 17.CANADA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 18.CANADA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 19.MEXICO WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 20.MEXICO WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 21.EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 22.EUROPE WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 23.EUROPE WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 24.GERMANY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 25.GERMANY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 26.FRANCE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 27.FRANCE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 28.UK WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 29.UK WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 30.ITALY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 31.ITALY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 32.SPAIN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 33.SPAIN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 34.REST OF EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 35.REST OF EUROPE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 36.ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 37.ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 38.ASIA-PACIFIC WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 39.JAPAN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 40.JAPAN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 41.CHINA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 42.CHINA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 43.AUSTRALIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 44.AUSTRALIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 45.INDIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 46.INDIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 47.SOUTH KOREA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 48.SOUTH KOREA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 49.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 50.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 51.LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 52.LAMEA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)

TABLE 53.LAMEA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)

TABLE 54.BRAZIL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 55.BRAZIL WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 56.SAUDI ARABIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 57.SAUDI ARABIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 58.SOUTH AFRICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 59.SOUTH AFRICA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 60.REST OF LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)

TABLE 61.REST OF LAMEA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)

TABLE 62.ABBOTT: COMPANY SNAPSHOT

TABLE 63.ABBOTT: OPERATING BUSINESS SEGMENTS

TABLE 64.ABBOTT: PRODUCT PORTFOLIO

TABLE 65.IRHYTHM: COMPANY SNAPSHOT

TABLE 66.IRHYTHM: OERATING SEGMENT

TABLE 67.IRHYTHM: PRODUCT PORTFOLIO

TABLE 68.J&J: COMPANY SNAPSHOT

TABLE 69.J&J: OPERATING BUSINESS SEGMENTS

TABLE 70.J&J: PRODUCT PORTFOLIO

TABLE 71.PHILIPS: COMPANY SNAPSHOT

TABLE 72.PHILIPS: OPERATING SEGMENTS

TABLE 73.PHILIPS: PRODUCT PORTFOLIO

TABLE 74.L’OREAL: COMPANY SNAPSHOT

TABLE 75.L’OREAL: OPERATING SEGMENTS

TABLE 76.L’OREAL: PRODUCT PORTFOLIO

TABLE 77.LIFESIGNALS: COMPANY SNAPSHOT

TABLE 78.LIFESIGNALS: OERATING SEGMENT

TABLE 79.LIFESIGNALS: PRODUCT PORTFOLIO

TABLE 80.MEDTRONIC: COMPANY SNAPSHOT

TABLE 81.MEDTRONIC: OPERATING SEGMENTS

TABLE 82.MEDTRONIC: PRODUCT PORTFOLIO

TABLE 83.QUALCOMM: COMPANY SNAPSHOT

TABLE 84.: OERATING SEGMENT

TABLE 85.QUALCOMM: PRODUCT PORTFOLIO

TABLE 86.VITALCONNECT: COMPANY SNAPSHOT

TABLE 87.VITALCONNECT: OERATING SEGMENT

TABLE 88.VITALCONNECT: PRODUCT PORTFOLIO

TABLE 89.VIVALNK: COMPANY SNAPSHOT

TABLE 90.VIVALNK: OERATING SEGMENT

TABLE 91.VIVALNK: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL WEARABLE PATCH MARKET SEGMENTATION

FIGURE 02.TOP INVESTMENT POCKETS

FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020

FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020

FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020

FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS

FIGURE 07.HIGH BARGAINING POWER OF BUYERS

FIGURE 08.HIGH THREAT OF SUBSTITUTES

FIGURE 09.MODERATE THREAT OF NEW ENTRANTS

FIGURE 10.MODERATE INTENSITY OF RIVALRY

FIGURE 11.TOP PLAYER POSITIONING, 2019

FIGURE 12.IMPACT ANALYSIS

FIGURE 13.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 14.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 15.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 16.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 17.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY COUNTRY, 2019 & 2027 (%)

FIGURE 18.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 19.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY COUNTRY, 2019 & 2027 (%)

FIGURE 20.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 21.ABBOTT: NET SALES, 2017–2019 ($MILLION)

FIGURE 22.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 23.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 24.IRHYTHM: NET SALES, 2017–2019 ($MILLION)

FIGURE 25.J&J: NET SALES, 2017–2019 ($MILLION)

FIGURE 26.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 27.J&J: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 28.PHILIPS: NET SALES, 2017–2019 ($MILLION)

FIGURE 29.PHILIPS: REVENUE SHARE BY SEGMENT, 2019 (%)

FIGURE 30.PHILIPS: REVENUE SHARE BY REGION, 2019(%)

FIGURE 31.L’OREAL: NET SALES, 2017–2019 ($MILLION)

FIGURE 32.L’OREAL: REVENUE SHARE BY SEGMENT, 2019 (%)

FIGURE 33.L’OREAL: REVENUE SHARE BY REGION, 2019 (%)

FIGURE 34.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)

FIGURE 35.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)

FIGURE 36.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)

FIGURE 37.QUALCOMM: NET SALES, 2018–2020 ($MILLION)

FIGURE 38.QUALCOMM: REVENUE SHARE, BY SEGMENT, 2020 (%)

FIGURE 39.QUALCOMM: REVENUE SHARE, BY REGION, 2020 (%)

 

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$6168
This license allows only one user to access the PDF.

Enterprise License

Electronic (PDF)
$9663
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

North America Hand Sanitizer Gel and Hand Soap Market
North America Hand Sanitizer Gel and Hand Soap Market

120 Pages
Type: Report
Code: QYRE-Othe-0X433
Tue Apr 27 15:11:25 UTC 2021

Add to Cart

Clinical Electronic Thermometers Market
Global Clinical Electronic Thermometers Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Othe-2V432
Thu Mar 25 13:27:19 UTC 2021

Add to Cart

Household Ultrasonic Humidifier Market
Household Ultrasonic Humidifier Market

120 Pages
Type: Report
Code: QYRE-Othe-2Z433
Thu Mar 25 13:37:35 UTC 2021

Add to Cart

Home Nebulizer Market
Global Home Nebulizer Market Insights and Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Othe-2N434
Thu Mar 25 13:50:52 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0